The novel use of combined IL-1 and IL-6 inhibition in a patient with severe, aggressive, erosive, systemic-onset juvenile idiopathic arthritis
(Eur J Rheumatol 2017; 4: 68-69) DOI: 10.5152/eurjrheum.2016.055
(Eur J Rheumatol 2017; 4: 68-69) DOI: 10.5152/eurjrheum.2016.055